INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1938542776 doctor patient]( "Why Clinical Trial Demographics Don't Match Real-World Populations")
Why Clinical Trial Demographics Don't Match Real-World PopulationsRepresentative trial demographics reduce bias, strengthen safety insights, and ensure therapies work for all. Learn why diversity is essential for accurate data and better health outcomes.
-
![GettyImages-1819626829 patient recruitment]( "A Community-Focused Approach To Metabolic Disease Trials")
A Community-Focused Approach To Metabolic Disease TrialsLearn how innovative strategies like free health exams, community engagement, and a comprehensive patient database helped this project achieve rapid enrollment with a high level of patient diversity.
-
![How RWD Reshapes Patient Recruitment Strategies]( "How RWD Reshapes Patient Recruitment Strategies")
How RWD Reshapes Patient Recruitment StrategiesDiscover how real-world data (RWD) is transforming patient recruitment by shifting from traditional site-centered methods to a patient-first approach.
-
![diversity - equality iStock-1303294233]( "Practical Strategies For Diverse Trial Recruitment")
Practical Strategies For Diverse Trial RecruitmentThe clock is ticking on the requirement for pharmaceutical companies to include FDA-mandated diversity action plans for pivotal studies in clinical trials.
-
RTSM Rescue Studies Are On The Rise5/26/2026
As RTSM technology continues to evolve, clinical trial rescues are becoming increasingly common. Explore the rise of the rescue trend and why more sponsors are ready to change course.
-
Overcoming Challenges In Obesity Trials2/12/2026
Obesity trials face high dropout rates due to long durations and complex requirements. Overcome these hurdles with personalized engagement, expert lifestyle support, and proactive patient care.
-
The Implications Of Semaglutide's Connect To Increased Risk Of NAION2/18/2025
Explore the implications of a connection between semaglutide and an increased risk of non-arteritic anterior ischemic optic neuropathy (NAION).
-
Navigating The 7 Biggest Challenges In Rare Disease Clinical Trials4/11/2025
Discover how partnering with specialized rare disease CROs allows drug sponsors to accelerate treatment development, navigate trial complexities, and ultimately improve patient outcomes.
-
Expanding Clinical Research In East Africa With Digital Innovation12/11/2025
Africa carries 25% of the world’s disease burden but hosts only 1% of clinical trials. Discover technology-driven strategies that close this gap and transform research access in underserved regions.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![iStock-1152216276-skin-dermatology]( "Innovative Dermatological Assessments For Early Drug Development")
Our dermatology studies provide results that are more than skin deep. Because the skin is the largest and most easily accessible organ, our dermatology research also facilitates drug development in other areas, including immunology and endocrinology. In addition, we are engaged in studying ways to improve wound healing.
-
![GettyImages-165180340-digital-recruitment-people-patients]( "Accelerate Post-Approval Research By Streamlining the Entire Study Lifecycle")
Streamline post-approval research by embedding studies into routine clinical care. Reduce site burden and capture high-quality data for label expansion and regulatory needs.
-
![iStock-493302504-scientist-lab-development]( "Pre-Formulation And Material Sciences")
Our formulation development and material sciences experts have over 30 years’ experience in pre-formulation and solid state characterization.
-
![GettyImages-1165576018 clinical solution]( "Clinical Solutions For Early-Phase Drug Development")
Altasciences provides deep expertise in all clinical pharmacology studies required for successful regulatory submission across a wide range of therapeutic areas.
View the complete resource library.
Contact an Altasciences expert to learn more about their comprehensive clinical solution.
-
![GettyImages-2176126405-digital-puzzle]( "First-In-Human To Proof-Of-Concept: The DVCR Continuity Model")
With a single, consistent team from FIH to Proof-of-Concept, this Continuity Model eliminates fragmented handoffs to keep program knowledge intact and speed your path to Phase II.
